MyFinsight
Home
Blog
About
Prepaid and other
current assets
$1,252,670
Cash
$186,014
(111.33%↑ Y/Y)
Restricted cash
$20,000
(0.00%↑ Y/Y)
Accounts receivable
$2,058
(-89.15%↓ Y/Y)
Investment in gmp bio at fair
value
$388,000,000
(1612.78%↑ Y/Y)
Goodwill, net of
impairment
$2,788,230
(0.00%↑ Y/Y)
Total current assets
$1,460,742
(961.65%↑ Y/Y)
Investment in equity
securities
$1,400,000
In process r&d
$1,101,760
(0.00%↑ Y/Y)
Total assets
$394,750,732
(1379.53%↑ Y/Y)
Total liabilities and
stockholders equity
$394,750,732
(1379.53%↑ Y/Y)
Total stockholders
equity
$263,439,379
(3462.93%↑ Y/Y)
Total liabilities
$131,311,353
(580.83%↑ Y/Y)
Non-controlling interests
-$1,121,672
(-23.66%↓ Y/Y)
Total oncotelic
therapeutics, inc....
$264,561,051
(3087.11%↑ Y/Y)
Deferred income tax
liability
$111,550,000
Total current
liabilities
$17,906,958
(-7.15%↓ Y/Y)
Convertible long-term debt,
net of costs
$1,854,395
Accumulated equity
$209,433,535
(650.25%↑ Y/Y)
Additional paid-in capital
$50,556,882
(19.58%↑ Y/Y)
Common stock, 0.01 par
value 750,000,000...
$4,570,125
(11.93%↑ Y/Y)
Convertible preferred
stock, 0.01 par value,...
$509
Convertible debt and
short-term debt, net of...
$7,925,881
Convertible debt and
short-term debt, net of...
$4,114,684
Contingent consideration
$2,625,000
(0.00%↑ Y/Y)
Accounts payable and
accrued liabilities
$2,554,999
(2.72%↑ Y/Y)
Accounts payable to
related party-Related...
$349,138
(0.59%↑ Y/Y)
Derivative liability on
notes
$337,256
(20.97%↑ Y/Y)
Back
Back
Balance Sheet
Oncotelic Therapeutics, Inc. (OTLC)
Oncotelic Therapeutics, Inc. (OTLC)
source: myfinsight.com